603 related articles for article (PubMed ID: 7061309)
1. Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine.
Krakowka S; Olsen RG; Axthelm MK; Rice J; Winters K
J Am Vet Med Assoc; 1982 Jan; 180(2):137-9. PubMed ID: 7061309
[TBL] [Abstract][Full Text] [Related]
2. Development of a modified live, canine origin parvovirus vaccine.
Bass EP; Gill MA; Beckenhauer WH
J Am Vet Med Assoc; 1982 Nov; 181(9):909-13. PubMed ID: 7141990
[TBL] [Abstract][Full Text] [Related]
3. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
4. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
[TBL] [Abstract][Full Text] [Related]
6. Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins.
Pardo MC; Bauman JE; Mackowiak M
Am J Vet Res; 1997 Aug; 58(8):833-6. PubMed ID: 9256965
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
Litster A; Nichols J; Volpe A
Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
[TBL] [Abstract][Full Text] [Related]
8. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
[TBL] [Abstract][Full Text] [Related]
10. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia.
Mitchell SA; Zwijnenberg RJ; Huang J; Hodge A; Day MJ
Aust Vet J; 2012 Dec; 90(12):468-73. PubMed ID: 23186088
[TBL] [Abstract][Full Text] [Related]
11. Use of modified live feline panleukopenia virus vaccine to immunize dogs against canine parvovirus.
Pollock RV; Carmichael LE
Am J Vet Res; 1983 Feb; 44(2):169-75. PubMed ID: 6299142
[TBL] [Abstract][Full Text] [Related]
12. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
[TBL] [Abstract][Full Text] [Related]
13. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
Larson LJ; Schultz RD
Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
[TBL] [Abstract][Full Text] [Related]
14. A modified live canine parvovirus vaccine. II. Immune response.
Carmichael LE; Joubert JC; Pollock RV
Cornell Vet; 1983 Jan; 73(1):13-29. PubMed ID: 6337780
[TBL] [Abstract][Full Text] [Related]
15. Development of hypertrophic osteodystrophy and antibody response in a litter of vaccinated Weimaraner puppies.
Harrus S; Waner T; Aizenberg ; Safra N; Mosenco A; Radoshitsky M; Bark H
J Small Anim Pract; 2002 Jan; 43(1):27-31. PubMed ID: 11833821
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of protective antibody titers for canine distemper virus and canine parvovirus in dogs entering a Florida animal shelter.
Lechner ES; Crawford PC; Levy JK; Edinboro CH; Dubovi EJ; Caligiuri R
J Am Vet Med Assoc; 2010 Jun; 236(12):1317-21. PubMed ID: 20550446
[TBL] [Abstract][Full Text] [Related]
17. Serum antibody response to canine parvovirus, canine adenovirus-1, and canine distemper virus in dogs with known status of immunization: study of dogs in Sweden.
Olson P; Klingeborn B; Hedhammar A
Am J Vet Res; 1988 Sep; 49(9):1460-6. PubMed ID: 3223653
[TBL] [Abstract][Full Text] [Related]
18. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
[TBL] [Abstract][Full Text] [Related]
19. Response of gray foxes to modified live-virus canine distemper vaccines.
Halbrooks RD; Swango LJ; Schnurrenberger PR; Mitchell FE; Hill EP
J Am Vet Med Assoc; 1981 Dec; 179(11):1170-4. PubMed ID: 7199036
[TBL] [Abstract][Full Text] [Related]
20. Studies on canine parvovirus infections: development of an inactivated vaccine.
Eugster AK
Am J Vet Res; 1980 Dec; 41(12):2020-4. PubMed ID: 7212436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
